Concordia International Corp Can’t Burn Your Short Portfolio. Just Reaches 52-Week Low

 Concordia International Corp Can't Burn Your Short Portfolio. Just Reaches 52 Week Low

The stock of Concordia International Corp (TSE:CXR) hit a new 52-week low and has $3.78 target or 13.00% below today’s $4.34 share price. The 9 months bearish chart indicates high risk for the $211.71 million company. The 1-year low was reported on Nov, 1 by If the $3.78 price target is reached, the company will be worth $27.52M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 331,137 shares traded hands. Concordia International Corp (TSE:CXR) has declined 86.16% since March 28, 2016 and is downtrending. It has underperformed by 89.18% the S&P500.

Concordia International Corp (TSE:CXR) Ratings Coverage

Out of 4 analysts covering Concordia Healthcare Corp (TSE:CXR), 1 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 25% are positive. $135 is the highest target while $4.50 is the lowest. The $32.90 average target is 658.06% above today’s ($4.34) stock price. Concordia Healthcare Corp has been the topic of 23 analyst reports since August 11, 2015 according to StockzIntelligence Inc. The firm has “Outperform” rating given on Monday, October 31 by RBC Capital Markets. RBC Capital Markets maintained the shares of CXR in a report on Monday, June 20 with “Outperform” rating. The stock of Concordia International Corp (TSE:CXR) has “Outperform” rating given on Tuesday, June 7 by RBC Capital Markets. The stock of Concordia International Corp (TSE:CXR) has “Sector Outperform” rating given on Wednesday, September 9 by Scotia Capital. RBC Capital Markets maintained it with “Outperform” rating and $118 target price in Tuesday, August 11 report. The firm earned “Outperform” rating on Friday, January 8 by RBC Capital Markets. The firm earned “Hold” rating on Thursday, December 3 by Mackie. The stock has “Outperform” rating given by RBC Capital Markets on Monday, May 16. As per Monday, October 17, the company rating was maintained by RBC Capital Markets. As per Monday, October 24, the company rating was maintained by RBC Capital Markets.

More notable recent Concordia International Corp (TSE:CXR) news were published by: which released: “Concordia International Corp. Announces Communication With CMA” on October 25, 2016, also with their article: “Concordia International Corp. Announces CEO Transition Plan” published on October 21, 2016, published: “Shareholder Class Action Filed Against Concordia International Corp. – CXRX” on August 17, 2016. More interesting news about Concordia International Corp (TSE:CXR) were released by: and their article: “Concordia International Corp takeover unlikely – Goldman” published on September 27, 2016 as well as‘s news article titled: “Concordia International Corp. Announces FDA Approval for New Photofrin® Laser” with publication date: June 30, 2016.

Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $211.71 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment